What is the etiology of IgA (Immunoglobulin A) nephropathy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Etiology of IgA Nephropathy

IgA nephropathy is an autoimmune disease caused by the formation and glomerular deposition of immune complexes containing galactose-deficient IgA1 (gd-IgA1) and corresponding IgG or IgA autoantibodies. 1, 2

Pathogenic Mechanism: The Multi-Hit Hypothesis

The etiology follows a sequential four-hit process that explains disease development from immune dysregulation to kidney injury 3, 4, 2:

Hit 1: Production of Aberrant IgA1

  • Patients produce elevated levels of IgA1 with undergalactosylated O-glycans in the hinge region (galactose-deficient IgA1), which represents the primary immunochemical abnormality 4, 2
  • This aberrant glycosylation alone does not cause disease but serves as the autoantigen 4
  • The precise origin of gd-IgA1 production involves genetic, epigenetic, and immunological factors that remain incompletely understood 3

Hit 2: Autoantibody Formation

  • Glycan-specific IgG and IgA autoantibodies develop that recognize the undergalactosylated IgA1 as foreign 4, 2
  • These autoantibodies often have cross-reactivity with antigens from mucosal microorganisms and may arise from recurrent mucosal infections, particularly tonsillitis 4
  • B cells responding to mucosal infections are implicated in producing the nephritogenic IgA1 4

Hit 3: Immune Complex Formation and Deposition

  • Circulating IgA1-IgG immune complexes form and deposit in the glomerular mesangium via an unidentified receptor 4, 2
  • Decreased hepatic clearance of these complexes contributes to their accumulation and subsequent glomerular deposition 4
  • Glomerular immunodeposits in IgAN are enriched for both gd-IgA1 and the corresponding IgG autoantibodies 2

Hit 4: Glomerular Injury

  • Deposited immune complexes activate mesangial cells, triggering local production of cytokines, growth factors, and complement activation 4
  • This leads to mesangial proliferation, inflammation, and subsequent podocyte and tubulointerstitial injury through mesangio-podocytic-tubular crosstalk 4

Contributing Factors

Genetic Predisposition

  • Important genetic factors promote overproduction of aberrant IgA1, though specific genes remain under investigation 4, 5

Environmental Triggers

  • Recurrent mucosal infections, especially upper respiratory tract infections and tonsillitis, may trigger autoantibody production and disease flares 4
  • Environmental factors interact with genetic susceptibility to drive disease development 5

Immune System Abnormalities

  • Both innate and adaptive immune mechanisms are dysregulated, involving abnormal B-cell and T-cell responses 5
  • Mucosal immune system dysfunction contributes to aberrant IgA1 production 5

Diagnostic Confirmation

The definitive diagnostic feature is mesangial dominant or co-dominant IgA deposits on kidney biopsy 6, with electron microscopy revealing electron-dense deposits in the mesangium, typically with C3 co-deposition and less commonly C1q 6

Clinical Implications

Circulatory levels of gd-IgA1 and IgG autoantibodies predict disease progression, supporting their pathogenic role 2. The kidneys are damaged as innocent bystanders in this systemic autoimmune process where immune complexes deposit in glomeruli 2.

References

Research

New insights into the pathogenesis of IgA nephropathy.

Pediatric nephrology (Berlin, Germany), 2018

Research

Pathogenesis of IgA nephropathy.

Nature reviews. Nephrology, 2012

Research

Immune abnormalities in IgA nephropathy.

Clinical kidney journal, 2023

Guideline

IgA Nephropathy Pathogenesis and Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.